Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 86 member B2 (FAM86B2) is a human gene encoding a protein predicted to possess N-methyltransferase activity, possibly involved in protein lysine methylation and regulation of translation. Functional characterization is limited: evidence for direct biological function, disease association, or utility as a therapeutic target or biomarker is currently lacking. FAM86B2 is subject to post-translational modification including phosphorylation and ubiquitination. A variant at S33 (S33R) has been reported in uterine cancer samples, but its clinical significance remains unclear. Its closest annotated paralog is EEF2KMT, another methyltransferase active in translation-related protein modification[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 86 member B2 (FAM86B2).